Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Wells Fargo cut Warner Bros. Discovery, Inc. WBD price target from $16 to $12. Wells Fargo analyst Steven Cahall downgraded the stock from Overweight to Equal-Weight. Warner Bros. Discovery shares rose 0.4% to close at $10.62 on Friday. See how other analysts view this stock.
- Barclays boosted the price target for Alvotech ALVO from $10 to $17. Barclays analyst Balaji Prasad upgraded the stock from Equal-Weight to Overweight. Alvotech shares rose 2.9% to close at $14.65 on Friday. See how other analysts view this stock.
- Keybanc raised the price target for Alphabet Inc. GOOGL from $153 to $165. Keybanc analyst Justin Patterson maintained an Overweight rating. Alphabet shares gained 0.2% to close at $152.18 on Friday. See how other analysts view this stock.
- JP Morgan raised Dollar General Corporation DG price target from $108 to $120. JP Morgan analyst Matthew Boss maintained an Underweight rating. Dollar General shares rose 0.4% to close at $133.45 on Friday. See how other analysts view this stock.
- Jefferies boosted the price target for ZIM Integrated Shipping Services Ltd. ZIM from $14 to $20. Jefferies analyst Omar Nokta upgraded the stock from Hold to Buy. ZIM Integrated Shipping shares fell 2.6% to close at $13.44 on Friday. See how other analysts view this stock.
- Needham increased the price target for Bel Fuse Inc. BELFB from $70 to $77. Needham analyst James Ricchiuti maintained a Buy rating. Bel Fuse shares fell 0.9% to close at $66.22 on Friday. See how other analysts view this stock.
- Barclays raised American Express Company AXP price target from $216 to $220. Barclays analyst Mark Devries maintained an Overweight rating. American Express shares gained 7.1% to close at $201.43 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. increased Oncternal Therapeutics, Inc. ONCT price target from $2 to $30. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating. Oncternal Therapeutics shares gained 0.6% to close at $9.02 on Friday. See how other analysts view this stock.
- UBS raised Rapid7, Inc. RPD price target from $53 to $70. UBS analyst Roger Boyd upgraded the stock from Neutral to Buy. Rapid7 shares fell 1.5% to close at $54.55 on Friday. See how other analysts view this stock.
- Citigroup boosted American Airlines Group Inc. AAL price target from $14 to $20. Citigroup analyst Stephen Trent upgraded the stock from Neutral to Buy. American Airlines shares fell 1.5% to close at $15.13 on Friday. See how other analysts view this stock.
Check This Out: Nucor, Super Micro Computer And 3 Stocks To Watch Heading Into Monday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: NewsPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalyst forecastsPT Changes
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in